SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending amid ongoing speculation of a potential acquisition by a group including Stripe and Advent, with the community actively debating whether management will secure a premium valuation. Traders are closely monitoring institutional call sweeps and technical breakouts, viewing the stock as a deeply undervalued asset ripe for a higher buyout offer or a significant long-term turnaround.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending following a massive surge in institutional accumulation and positive institutional ownership filings, fueling community sentiment that the stock is poised for a significant re-rating. Investors are hyper-focused on the company's strong revenue guidance, expanding ATC network, and upcoming registrational data for non-small cell lung cancer, which many view as a transformative catalyst for long-term valuation.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing significant volatility driven by investor concerns over security vulnerabilities in its VMware products alongside broader semiconductor sector pressure. Despite these challenges, the community remains actively divided, with many traders viewing the price dips as buying opportunities due to the company's strong long-term fundamentals in AI chip revenue and networking.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is facing intense community debate and volatility as its price drops below the psychological one-dollar threshold, with investors split between buying the dip and fearing a continued slide. The conversation is heavily focused on uncertainty regarding upcoming regulatory clarity and skepticism over institutional adoption.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind the stock following a landmark patent settlement with Samsung and renewed legal pressure on major memory manufacturers. The community is actively discussing the stock's significant long-term potential, with many members anticipating a short squeeze and further licensing deals as key catalysts for sustained growth.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors monitor heavy short interest and speculative anticipation for upcoming quarterly results, with the community actively debating whether the companys recent AI infrastructure expansion can trigger a potential squeeze or major revaluation. While some vocal bears point to historical concerns regarding dilution and management communication, bulls are emphasizing strong revenue growth trends and the strategic positioning of their data center projects as catalysts for a significant turnaround.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The IWM is trending as small caps rally alongside major indices, with the community actively debating whether this outperformance signals a broader market rotation or remains a speculative 'bull trap' despite persistent concerns over yields and economic data.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is surging as investors react to a significant government policy catalyst involving new tariffs on imported drones, which is expected to bolster domestic manufacturing and defense-related supply chains. The community is actively debating the stock's potential as a long-term defense play, with heavy discussions revolving around recent analyst coverage, insider alignment through new performance-based compensation, and broader industry growth.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors weigh strong Q2 results, highlighted by robust revenue and raised EBITDA guidance, against ongoing volatility driven by sector-specific reimbursement uncertainty. While community discussions remain deeply polarized between long-term bulls highlighting institutional accumulation and DaVita's contract win versus skeptics frustrated by share price suppression and lack of leadership transparency.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing heavy trading activity as investors monitor the upcoming Phase 3 trial readouts for DURAVYU, with community sentiment split between excitement over potential durability advantages and caution regarding short interest and pending binary trial catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.

QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging

QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging...

Here's How ABT Broadens Diagnostics Growth Base With Oncology Expansion

Abbott broadens Diagnostics growth with Exact Sciences, as Cancer Diagnostics gains and resilient routine testing offset respiratory weakness.

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of +425.00% and +2.65%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

QuidelOrtho Reports Second Quarter 2026 Financial Results

QuidelOrtho Reports Second Quarter 2026 Financial Results QuidelOrtho Reports Second Quarter 2026 Financial Results PR Newswire SAN DIEGO, Aug. 6, 2026 Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth Excluding China, total revenue grew 6...

Implied Volatility Surging for QuidelOrtho Stock Options

Investors need to pay close attention to QDEL stock based on the movements in the options market lately.

Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates

Lilly (LLY) delivered earnings and revenue surprises of +39.43% and +13.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

TEM Q2 Loss Narrower Than Expected, Revenues Beat, Stock Up

Tempus AI climbs 6.6% after its second-quarter loss narrows, revenues beat estimates and 2026 sales guidance rises on diagnostics and data growth.

ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise

Align Technology shares rise after Q2 earnings and revenues beat estimates, fueled by record Clear Aligner shipments and wider non-GAAP margins.

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

QuidelOrtho Corporation

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally

Equity

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info